Overexpression of p53 and HER-2/neu and c-myc in primary fallopian tube carcinoma

Gynecologic and Obstetric Investigation

Volumn 49, Issue 1, 2000, Pages 47-51

  Chung, T K H ^a   Cheung, T H ^a   To, K F ^a   Wong, Y F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adenocarcinoma; c myc; Fallopian tube; HER 2 neu; Overexpression; p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; HUMAN; ONCOGENE C MYC; ONCOGENE NEU; PRIORITY JOURNAL; UTERINE TUBE CARCINOMA;

EID: 0033977691     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000010212     Document Type: Article

References (12)

1. Eddy GL, Copeland LJ, Gershenson DM, Atkinson EN, Wharton JT, Rutledge FN: Fallopian tube carcinoma. Obstet Gynecol 1984;64: 546-547.
2. Lacy MQ, Hartmann LC, Keeney GL, Cha SC, Wieand HS, Podratz KC, Rochc PC: c-erbB-2 and p53 expression in fallopian tube carcinoma. Cancer 1995;75:2891-2896.
3. Stuhlinger M, Rosen AC, Dobianer K, Hruza C, Helmer H, Kein M, Koukai T, Reiner A, Klein M, Spona J: HER-2 oncogene is not amplified in primary carcinoma of the fallopian tube. Austrian Cooperative Study Group for fallopian tube carcinoma. Oncology 1995; 52:397-399.
4. Mizuuchi H, Mori Y, Sato K, Kamiya H, Okamura N. Nasim S, Garrett CT, Kudo R: High incidence of point mutation in K-ras codon 12 in carcinoma of the fallopian tube. Cancer 1995;76:86-90.
5. Runnebaum IB, Kohler T, Stickeler E, Kieback HR, Kreienberg R: P53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma. Br J Cancer 1996;74: 1157-1160.
6. Slamon DJ, Godolphine W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:702-712.
7. Finn WF, Javert CT: Primary and metastatic carcinoma of the fallopian tube. Cancer 1949; 2:802.
8. International Histological Classification of Tumors No 13. Geneva, World Health Organization, 1975.
9. Creaseman WT: Announcement, FIGO stages 1988 Revisions. Gynecol Oncol 1989;35:125-127.
10. Bishop JM: Molecular themes in oncogenesis. Cells 1991;64:235-248.
11. Stewart J, Evan G, Watson J, Sikora K: Detection of the c-myc gene product in colonic polyps and carcinomas. Br J Cancer 1986;53:1-6.
12. Subdaresan V, Forgacs IC, Wight DGD, Wilson B, Evan GI, Watson J: Abnormal distribution of c-myc oncogene product in familial adenocarcinomatous polyposis. J Clin Pathol 1987;40:1274-1281.